Global Anti-Inflammatory Peptides Market Growth 2023-2029

Global Anti-Inflammatory Peptides Market Growth 2023-2029

Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal\'s skin, lacerations of the musculature, mucous membranes, or injury into the air spaces of the lungs. Anti-inflammatory peptides act by hindering synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions. Anti-Inflammatory peptides are used to treat diseases such as psoriasis, multiple sclerosis, inflammatory bowel disease and other autoimmune diseases.

LPI (LP Information)' newest research report, the “Anti-Inflammatory Peptides Industry Forecast” looks at past sales and reviews total world Anti-Inflammatory Peptides sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-Inflammatory Peptides sales for 2023 through 2029. With Anti-Inflammatory Peptides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Inflammatory Peptides industry.

This Insight Report provides a comprehensive analysis of the global Anti-Inflammatory Peptides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Inflammatory Peptides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Anti-Inflammatory Peptides market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Inflammatory Peptides and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Inflammatory Peptides.

The global Anti-Inflammatory Peptides market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

North America has dominated the entire market in 2014, as it has presence of technologically updated systems, strong research & development, and high patient awareness levels in this region. Latin America is also expected to grow at a healthy rate as a result of increase in both private and public associations, causing an increase in the investment, thereby boosting the demand for the anti-inflammatory peptides. However, the Asia Pacific region is expected to witness lucrative growth during the forecast period owing to the rapidly improving healthcare infrastructure in the growing economies of India and China. Growing patient awareness levels among the population of this region coupled with high unmet needs of the patients is expected to further drive this region.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Inflammatory Peptides market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Cardiovascular Diseases
Gastrointestinal Diseases
Dermatological Diseases
Neurological Diseases
Otorhino Diseases & Ophthalmological
Respiratory Diseases & Pulmonary
Renal Diseases
Rheumatological & Autoimmune Diseases
Transplantation

Segmentation by application
Hospital Use
Clinic Use
Household
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Mylan Pharmaceuticals
Novartis AG
Rogne Bioscience
Merck Serono
F4 Pharma
Araim Pharmaceuticals, Inc.
Digna Biotech
Abbvie Corporation

Key Questions Addressed in this Report

What is the 10-year outlook for the global Anti-Inflammatory Peptides market?

What factors are driving Anti-Inflammatory Peptides market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Anti-Inflammatory Peptides market opportunities vary by end market size?

How does Anti-Inflammatory Peptides break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.